Global Narcotic Drugs Market
Market Size in USD Billion
CAGR :
% 
USD
14.62 Billion
USD
20.01 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 14.62 Billion |
 Market Size (Forecast Year) |
USD 20.01 Billion |
 CAGR |
% |
| Major Markets Players |
Global Narcotic Drugs Market Segmentation, By Source (Natural, Semi-synthetic, Synthetic), Indication (Pain Management, Cough, Diarrhea, Dysentery, Asthma, Others), Drug (Opium, Heroin, Codeine, Oxycodone, Hydrocodone, Tramadol, Morphine, Fentanyl, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2032
Narcotic Drugs Market Analysis
The global narcotic drugs market is anticipated to witness substantial growth during the forecast period 2025-2032. Many lead market players are making huge investment in research and development which in turn is boosting the growth of this market. Growing cases of severe pain associated with cancer and arthritis drive the narcotic drug market. COVID-19 also had a major impact on the market growth.
Narcotic Drugs Market Size
Global narcotic drugs market size was valued at USD 14.62 billion in 2024 and is projected to reach USD 20.01 billion by 2032, with a CAGR of 4.0% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes |
Narcotic Drugs Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Braeburn Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Johnsons & Johnsons Services Inc (U.S.), Boehringer Ingelheim International GmbH (U.S.), Allergan (U.S.), Sun Pharmaceutical Industries Ltd. (India), Sanofi (France), AstraZeneca (India), GlaxoSmithKline Plc. (U.K.), Novartis AG (U.S.), Pfizer Inc. (U.S.), Amneal Pharmaceuticals LLC. (U.S.), Alvogen (U.S), and Hikma Pharmaceuticals PLC (U.K.) |
|
Market Opportunities |
|
Narcotic Drugs Market Definition
Narcotic drugs are the kind of addictive substances which affects the cognitive status of the brain and induces euphoria. These drugs are the oldest and strongest pain-relieving agents which cause depression of central nervous system and produce a state of stupor in patients.
Narcotic Drugs Market Dynamics
Drivers
- Increase in Surgical Procedures
According to the National Center for Health Statistics, approximately 48 million surgical inpatient procedures were performed in the United States in 2009. And the procedure is increasing with the rise in minimally invasive surgeries. This boost the market growth.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increased Clinical Studies and Government Initiatives
Rising awareness about the drugs and studies that are conducted for development in identifying the harmful compositions for the body that by government and private companies for better knowledge of these drugs and antidotes is likely to drive the market growth.
- Increasing Demand for Retail Pharmacies
The rise in the number of narcotic drugs delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to treat the patients with these agents could curb the growth of the global antidotes market over a forecast period.
- High Cost
The huge expenditure associated with these agents surely hamper the market growth.
This global narcotic drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global narcotic drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Narcotic Drugs Market Scope
The global narcotic drugs market is segmented on the basis of source, indication, drug, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Source
- Natural
- Semi-synthetic
- Synthetic
Indication
- Pain Management
- Cough
- Diarrhea
- Dysentery
- Asthma
- Others
Drug
- Opium
- Heroin
- Codeine
- Oxycodone
- Hydrocodone
- Tramadol
- Morphine
- Fentanyl
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Narcotic Drugs Market Regional Analysis
The global narcotic drugs market is analyzed and market size insights and trends are provided by source, indication, drug, distribution channel and end-user as referenced above.
The major countries covered in the global narcotic drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for narcotic drugs market throughout the forecasted period due to increasing incidence of asthma, & severe pain and increased drug abuse.
Asia-Pacific dominates the market due to attracting attention of global leading players to establish numerous emerging economics with significant growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Narcotic Drugs Market Share
The global narcotic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global narcotic drugs market.
Narcotic Drugs Market Leaders Operating in the Market Are:
- Braeburn Inc. (U.S.)
- Takeda Pharmaceutical Company Limited (Japan)
- Johnsons & Johnsons Services Inc (U.S.)
- Boehringer Ingelheim International GmbH (U.S.)
- Allergan (U.S.)
- Sun Pharmaceutical Industries Ltd. (India)
- Sanofi (France)
- AstraZeneca (India)
- GlaxoSmithKline Plc. (U.K.)
- Novartis AG (U.S.)
- Pfizer Inc. (U.S.)
- Amneal Pharmaceuticals LLC. (U.S.)
- Alvogen (U.S.)
- Hikma Pharmaceuticals PLC (U.K.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
